DSM and TU Delft establish artificial intelligence laboratory to drive bioscience innovation | DSM

Geleen, NL, 11 Jan 2021 09:00 CET

Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, and TU Delft, ranked among the top universities in biotechnology research globally, today announce the establishment of the Artificial Intelligence Lab for Biosciences (the AI4B.io Lab). This laboratory will be the first of its kind in Europe to apply artificial intelligence (AI) to full-scale biomanufacturing, from microbial strain development to process optimization and scheduling.

The AI4B.io Lab will be part of the Dutch National Innovation Center for AI (ICAI), which works to keep the Netherlands at the forefront of knowledge and talent development in AI. It will be led by Professor Marcel Reinders, Director TU Delft Bioengineering Institute. DSM regards biosciences as an important tool for addressing climate change and resource scarcity and optimizing the global food system so will invest €2.5 million into the laboratory over the first five years.

With more than 150 years of experience, DSM has already developed an extensive portfolio of sustainable, bio-based solutions that help address some of the key challenges facing society. Now, developments in the understanding of biology, as well as major advances in digital transformation, are opening up exciting possibilities for new bio-based products, applications, and manufacturing processes. Integrating biosciences and digital technologies can help to reduce the time spent on innovation cycles, from prototyping to scaling and commercialization.

Cindy Gerhardt, Managing Director Planet B.io: ‘’At Planet B.io, we stimulate open innovation and collaboration between startups, corporations, and knowledge institutes to develop bio-based products and solutions. We look forward to working together with the AI4B.io Lab to maximize the potential of AI and biosciences.’’